The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Abstract

Different mechanisms could be involved in sex differences with regard to immunotherapy. These differences could be relevant to identify immunological targets in order to draw studies exploring novel combinations of immunotherapy agents.